GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases
2025 · Expert Opinion on Drug Delivery · 16 citations
https://doi.org/10.1080/17425247.2025.2466767
L
Ling Zuo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
129
Citations
6
h-index
5
i10-index
Ling Zuo is an academic researcher from Nantong University. The author has contributed to research in topics: Ferroptosis and cancer prognosis & MicroRNA in disease regulation & RNA modifications and cancer. The author has an h-index of 6, co-authored 16 publications.
ORCID: 0000-0002-6607-2272Papers by this author
worksPoor reporting quality and high proportion of missing data in economic evaluations alongside pragmatic trials: a cross-sectional survey
2025 · BMC Medical Research Methodology · 1 citations
https://doi.org/10.1186/s12874-025-02519-z
CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21839747
Identification of cancer cell-intrinsic biomarkers associated with tumor progression and characterization of SFTA3 as a tumor suppressor in lung adenocarcinomas
2025 · BMC Cancer · 0 citations
https://doi.org/10.1186/s12885-024-13395-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat